ADMA Biologics, Inc.ADMANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank93
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P93
Near historical high
vs 2Y Ago
5.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$50.40M-57.5%
2024$118.67M+1248.5%
2023$8.80M+114.8%
2022$-59.51M+47.0%
2021$-112.37M-10.2%
2020$-102.00M-33.9%
2019$-76.19M-21.6%
2018$-62.68M-68.2%
2017$-37.27M-104.0%
2016$-18.27M-